Status:
COMPLETED
The Effectiveness of Battlefield Acupuncture (BFA) With Standard Therapy in Gynecological Cancer Pain
Lead Sponsor:
Indonesia University
Conditions:
Gynecologycal Cancer
Cancer Related Pain
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Pain is one of the most important symptoms of cancer patients, with nearly 40% of all cancer patients experiencing moderate to severe pain. Gynecological oncology patients on palliative care have a ch...
Detailed Description
This study was conducted using a single blinded randomized control clinical trial design in 58 female patients who are hospitalized aged 18-65 years, have a diagnosis of gynecological cancer, with a V...
Eligibility Criteria
Inclusion
- Patient diagnosed with gynecological cancer.
- Women over 18 years to 65 years
- Subjects experiencing pain in cancer, with VAS ≥4, namely pain that caused by
- tumors,
- before or during a therapeutic process (radiation therapy, chemotherapy or postoperatively).
- side effect or the result of toxicity of cancer treatment.
- Willing to participate in this research and sign informed consent
Exclusion
- The patient has a medical emergency / hemodynamically unstable.
- Uncooperative patients, with serious psychological disorders, no currently undergoing psychiatric treatment, aggressive behavior, no allow for acupuncture.
- Patients with blood clotting disorders, with platelets \<50.000114 and in neutropenic condition with \<1000 neutrophils. 114
- The patient has an allergy to stainless steel acupuncture needles.
- Wounds at the acupuncture point puncture sites, skin infections in the ears. On patients with eczema on the ears, external otitis or psoriasis.
- There is a tumor in the area that will be stabbed and stimulated in the stomach pregnant women, close to the heart, or in the area of the carotid sinus lymphedema, insertion into the prosthesis.
- Patients with heart rhythm disorders.
- The patient uses a pace maker.
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2023
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT06115330
Start Date
August 30 2023
End Date
December 19 2023
Last Update
February 5 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Fatmawati Hospital
Jakarta, DKI Jakarta, Indonesia, 12430
2
Persahabatan Hospital
Jakarta, DKI Jakarta, Indonesia, 13230
3
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430